MergerLinks Header Logo

Request Deal Involvement

Roche to acquire Poseida Therapeutics for $1.5bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Centerview Partners

financial advisors

Centerview Partners

Cooley

legal advisors

Cooley

Paul Weiss Rifkind Wharton & Garrison

legal advisors to financial advisors

Paul Weiss Rifkind Wharton & Garrison

Citigroup

financial advisors

Citigroup

Sidley Austin

legal advisors

Sidley Austin

Sodali & Co

pr advisors

Sodali & Co

Davy Corporate Finance

financial advisors

Davy Corporate Finance

or

Principals

POSEIDA THERAPEUTICS

target

POSEIDA THERAPEUTICS

ROCHE HOLDINGS AG

bidder

ROCHE HOLDINGS AG

MALIN CORPORATION PLC

vendor

MALIN CORPORATION PLC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Roche to acquire Poseida Therapeutics for $1.5bn.